ZytoVision develops and produces innovative in vitro diagnostic products, primarily focusing on core areas of solid and hematological tumor diagnostics, by using the FISH and CISH techniques. Nowadays, more and more genetic markers need to be evaluated on a patient’s sample to identify the appropriate treatment. These diagnostic requirements led ZytoVision to the development of new and unique probe designs as e.g., for the simultaneous detection of different genetic markers on only one slide. ZytoVision stands for a continuous product development process in cooperation with many international clinical partners as well as strict and thorough quality controls during our production processes of our more than 200 CE-certified in vitro diagnostic devices.

ZytoVision GmbH
Country exclusion: YES – available as exclusive distributors in Croatia and Bosnia and Herzegovina; non-exclusive partners in North Macedonia, Montenegro and Kosovo
Visit website